Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision. Johnson & Johnson (NYSE: JNJ) (the Company) today announced that vaccinations with the Company's COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization (EUA), following a decision from the United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA).
More:
prnewswire.com/news-releases/johnson--johnson-single-shot-covid-19-vaccinations-to-resume-in-
the-us-for-all-adults-aged-18-and-older-following-cdc-and-fda-decision-301276236.html
No comments:
Post a Comment